Wenbing Wu

673 total citations · 1 hit paper
18 papers, 486 citations indexed

About

Wenbing Wu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wenbing Wu has authored 18 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wenbing Wu's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Wenbing Wu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Wenbing Wu collaborates with scholars based in China and United States. Wenbing Wu's co-authors include Tiannan Wei, Zhi‐Zhong Chen, Jin Shang, Zhihong Wang, Shujun Zhang, Changzhen Sun, Hong Zhou, Shan Liu, Ji Liu and Lihong Chen and has published in prestigious journals such as World Journal of Gastroenterology, Oncotarget and Surgical Endoscopy.

In The Last Decade

Wenbing Wu

17 papers receiving 485 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics

2023 111 citations Wenbing Wu, Hong Zhou et al. Virology Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wenbing Wu China	10	347	225	86	38	36	18	486
Olga N. Hernández-de la Cruz Mexico	13	332 1.0×	165 0.7×	70 0.8×	67 1.8×	39 1.1×	22	502
Yinying Lu China	11	238 0.7×	114 0.5×	48 0.6×	69 1.8×	48 1.3×	35	445
Haiyan Du China	11	234 0.7×	128 0.6×	30 0.3×	49 1.3×	22 0.6×	22	346
Xinye Wang China	13	290 0.8×	121 0.5×	48 0.6×	76 2.0×	74 2.1×	45	503
Haosheng Tang China	9	296 0.9×	129 0.6×	35 0.4×	72 1.9×	58 1.6×	9	430
Zahra Bahmanpour Iran	10	349 1.0×	260 1.2×	23 0.3×	43 1.1×	25 0.7×	17	524
Patrick Santos Brazil	10	347 1.0×	143 0.6×	47 0.5×	50 1.3×	13 0.4×	14	448
Xi Tan Canada	7	162 0.5×	143 0.6×	35 0.4×	49 1.3×	28 0.8×	8	331
Simona Vișan Romania	11	201 0.6×	155 0.7×	30 0.3×	76 2.0×	42 1.2×	19	375

Countries citing papers authored by Wenbing Wu

Since Specialization

Citations

This map shows the geographic impact of Wenbing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbing Wu more than expected).

Fields of papers citing papers by Wenbing Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbing Wu. The network helps show where Wenbing Wu may publish in the future.

Co-authorship network of co-authors of Wenbing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbing Wu. A scholar is included among the top collaborators of Wenbing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbing Wu. Wenbing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Zhao, Shoujie, Yejing Zhu, Jinming Zhu, et al.. (2025). Liver resection versus interventional treatments for hepatocellular carcinoma patients with hypohepatia: a multicenter study. Surgical Endoscopy. 39(7). 4205–4216.

Chen, Ping, et al.. (2023). FAM72 family proteins as poor prognostic markers in clear cell renal carcinoma. Biochemistry and Biophysics Reports. 35. 101506–101506. 4 indexed citations

Wu, Wenbing, et al.. (2023). The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics. Virology Journal. 20(1). 6–6. 111 indexed citations breakdown →

Ke, Nengwen, Ziyao Wang, Bin Xiang, et al.. (2023). Copper deprivation enhances the chemosensitivity of pancreatic cancer to rapamycin by mTORC1/2 inhibition. Chemico-Biological Interactions. 382. 110546–110546. 10 indexed citations

Chen, Falin, et al.. (2022). High expression of DARS2 indicates poor prognosis in lung adenocarcinoma. Journal of Clinical Laboratory Analysis. 36(10). e24691–e24691. 8 indexed citations

Wu, Wenbing, Bin Xiang, Dan Chen, et al.. (2022). EGCG Enhances the Chemosensitivity of Colorectal Cancer to Irinotecan through GRP78-MediatedEndoplasmic Reticulum Stress. Journal of Oncology. 2022. 1–13. 14 indexed citations

Wu, Wenbing, Dan Chen, Bin Xiang, et al.. (2021). EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells. Journal of Cellular and Molecular Medicine. 25(16). 7913–7921. 30 indexed citations

Wu, Wenbing, et al.. (2020). Usnic Acid Inhibits Proliferation and Migration through ATM Mediated DNA Damage Response in RKO Colorectal Cancer Cell. Current Pharmaceutical Biotechnology. 22(8). 1129–1138. 14 indexed citations

Chen, Lihong, et al.. (2020). [Inhibition of Copper Transporter-1 by Ammonium Tetrathiocarbolybdate in the Treatment of Pancreatic Cancer].. PubMed. 51(5). 643–649. 3 indexed citations

10.

Shang, Jin, Shan Liu, Zhihong Wang, et al.. (2019). CircPAN3 contributes to drug resistance in acute myeloid leukemia through regulation of autophagy. Leukemia Research. 85. 106198–106198. 91 indexed citations

11.

Wu, Wenbing, et al.. (2019). Metformin mediated microRNA-7 upregulation inhibits growth, migration, and invasion of non-small cell lung cancer A549 cells. Anti-Cancer Drugs. 31(4). 345–352. 31 indexed citations

12.

Wu, Wenbing, et al.. (2019). [The Effect of Methylation Level of microRNA Promoter on the Expression of microRNAs and on the Proliferation, Migration and Invasion of Lung Cancer Cells].. PubMed. 50(2). 182–187. 2 indexed citations

13.

Shang, Jin, et al.. (2018). CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p–XIAP axis. Experimental Hematology. 70. 42–54.e3. 119 indexed citations

14.

Zhao, Yuan, et al.. (2018). [Variation of expression level and activity of coagulation factor ⅩⅢ in acute myeloid leukemia patients].. PubMed. 39(10). 859–861. 1 indexed citations

15.

Shang, Jin, et al.. (2018). [Effect of Expression Levels of MiRNA-132, -125, -143 and -145 on Autophagy and Apoptosis of Multiple Myeloma Cells].. PubMed. 26(6). 1688–1694. 5 indexed citations

16.

Huang, Yi, Jianbo Pan, Jiaying Zheng, et al.. (2017). Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq. Oncotarget. 8(22). 35973–35983. 5 indexed citations

17.

Huang, Yi, Jiaying Zheng, Feng Li, et al.. (2017). Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma. Oncotarget. 8(25). 40693–40704. 11 indexed citations

18.

Qiu, Funan, Yi Huang, Feng Li, et al.. (2016). Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling. World Journal of Gastroenterology. 22(16). 4226–4226. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact